A forty-eight-year-old principal in a Lagos law firm goes to bed most nights at about one in the morning, after the last brief has been read and the last WhatsApp from a partner answered, and rises a few minutes before six to drive from Lekki to Victoria Island before the traffic on Ozumba Mbadiwe closes. He has done this, in some version, for nineteen years. He drinks his first coffee before he has properly opened his eyes, his second at the office, and a third around three in the afternoon when the lull in concentration arrives. He has been on an antihypertensive for three years, and his GP's notes describe his blood pressure as "not well controlled, advised to reduce salt." His last HbA1c returned 6.4, which his GP described as borderline and which the patient understood to mean he should drink less Coca-Cola. His wife has mentioned, twice in the last year and not lightly either time, that he is not the same man on a Saturday morning that he was at fifty. He blames the firm. He has not, in any of these conversations, connected the antihypertensive, the HbA1c, the Saturday morning, or the slow erosion of his temper to the five hours of sleep he has been averaging for two decades.
This is not hypothetical. It is the most consistent clinical pattern in the Nigerian executive demographic across every age, both sexes, and every industry the practice sees. Chronic sleep deprivation is the single most accepted, most under-treated, most cardiometabolically destructive habit of the Nigerian principal class — and the clinical literature on what five hours of habitual sleep does to the body is now unambiguous in a way that primary care in Lagos and Abuja is not yet treating as such.
What chronic short sleep actually does
The honest summary is that five hours a night, sustained over years, attacks five connected systems in parallel, and the patient typically experiences each as a separate complaint to be managed separately. Naming them together is the first clinically useful thing a physician can do for the man at the top of this piece.
The first system is cardiovascular. Habitual sleep duration under six hours raises the incidence of hypertension, coronary events, and stroke independent of other risk factors, with effect sizes that hold across the large prospective cohorts in the United States, the United Kingdom, and Japan. The American Heart Association added sleep to its Life's Essential 8 framework in 2022, formally placing sleep duration alongside blood pressure, lipids, glucose, smoking, body weight, diet, and physical activity as a top-tier modifiable cardiovascular risk factor. The Lagos principal whose antihypertensive "is not well controlled" is, in many cases, not failing to respond to the drug. He is failing to give the drug a body that can respond. The chronic sympathetic activation produced by twenty years of short sleep undoes the drug's work every night, between one and six.
The second system is metabolic. Controlled metabolic-ward studies, beginning with the work of Spiegel, Leproult, and Van Cauter in the early 2000s and replicated repeatedly since, have shown that five or six nights of sleep restricted to four hours produces, in young healthy men, insulin sensitivity reductions of around thirty to forty percent and glucose tolerance patterns indistinguishable from early Type 2 diabetes. The principal's HbA1c of 6.4 is being read as a dietary problem. It is in many of these patients as much a sleep problem, and treating only the visible half of the equation produces the stubborn pre-diabetic drift the standard Nigerian executive panel records year on year.
The third system is hormonal, and it ties this piece back to the earlier work on erectile dysfunction as a cardiovascular diagnosis. Testosterone production in men is concentrated in the latter portions of REM sleep, which is the stage most aggressively curtailed when total sleep time is shortened. Published trials of one-week sleep restriction in young men show morning testosterone reductions of ten to fifteen percent — the equivalent, in endocrinological terms, of aging the man by a decade in a working week. In women, sleep disruption is documented as an independent contributor to ovulatory dysfunction, irregular cycles, lower implantation rates in IVF cohorts, and elevated cortisol patterns that interfere with the hypothalamic-pituitary-ovarian axis. The patient being worked up for fertility without anyone running a serious sleep history is being worked up incompletely.
The fourth system is cognitive. The seminal Van Dongen paper in Sleep in 2003 followed forty-eight subjects through fourteen consecutive nights of four, six, or eight hours in bed. After two weeks, the six-hour subjects showed cognitive deficits on objective tests of working memory and sustained attention equivalent to two consecutive nights of complete sleep deprivation. The four-hour group reached the same level of impairment in three days. Two findings from that paper matter more than the rest. The deficits accumulate slowly enough that subjects believe they have adapted — subjective alertness stabilises while objective performance keeps falling. And those deficits do not resolve with a single night of recovery sleep. The principal who tells his wife he is "fine on five hours" is reporting an internal experience that is real and an external performance that is, against a baseline he no longer remembers, materially degraded.
The fifth system is mood. The link between sleep architecture and depressive illness is one of the oldest established findings in psychiatry, with REM disturbance as both marker and amplifier of major depression. Chronic short sleep raises anxiety, irritability, and depressive symptom burden in non-depressed adults, and in adults with subclinical depressive tendencies it tips the balance reliably. The Saturday-morning version of the principal his wife is describing — quieter, shorter, less present — is not the inevitable arithmetic of his fifty-second year. It is, in many of these patients, an HPA axis chronically primed by twenty years of sleep loss, expressing itself as a flattening of affect on the one morning of the week that the schedule loosens enough to expose it.
A second case the workup is missing
A thirty-four-year-old strategy consultant in Asokoro has been trying to conceive with her husband for fourteen months. The fertility clinic — a serious one, not an open-market operation — has run the standard workup. Her partner's semen analysis is normal. Her hormone profile is broadly normal. Her ovarian reserve is appropriate for her age. Her thyroid is normal. The clinical team has offered, gently, to consider IVF.
She averages five and a half hours a night during the working week, with two-hour catch-up sleeps on Saturday and Sunday mornings she believes are restoring the deficit. Her LH surge, when she has tracked it, is sometimes textbook and sometimes erratic. Her cycle length has drifted from a stable twenty-eight days in her late twenties to a less stable twenty-six to thirty-two in the last two years. Nobody in the workup has taken a sleep history. Nobody has explained that ovulatory irregularity in young women is one of the better-documented downstream effects of chronic short sleep, and that the catch-up sleep model does not, on the published evidence, restore the hormonal axes the working week disturbs. She is being moved toward IVF without having been offered the cheaper and possibly decisive intervention of an extra ninety minutes a night for three months.
The practice sees this pattern often enough to treat it as a standing reason for a careful sleep history in any woman under forty being investigated for unexplained subfertility.
Why Nigerian work culture rewards the loss
The cultural reasons the Nigerian executive demographic sleeps badly are specific and worth naming, because they are surmountable once named.
The first is the badge of honour. "I was at the office until two" is a phrase used in Nigerian board rooms and the WhatsApp threads that connect them as evidence of seriousness rather than as clinical disclosure. The first generation of successful Nigerian professionals — the men and women now in their fifties and sixties who built their careers in environments where rest was equated with absence and absence with replaceability — passed to their juniors a working norm that treats sleep as the thing one cuts when the workload grows.
The second is the traffic tax. The drive from Lekki to Victoria Island at seven in the morning and back at eight in the evening shortens the available sleep window at both ends of the day, and the equivalent commute in Abuja does the same in milder form. A man whose working day begins at nine and ends at six is, in Lagos terms, a man whose physical day begins at six and ends at nine, and whose sleep window is therefore rarely more than six hours and usually closer to five.
The third is the blue-light environment of the late-night office, the senior-executive WhatsApp groups that run until midnight, and the obligation to attend the long evening events Nigerian professional life is structured around. Evening screen exposure shifts circadian onset later and shortens deep sleep early in the night. The same patient who could fall asleep at ten often cannot until one, because the physiological signal his pineal gland was meant to receive at nine has been overwritten by the screen.
The fourth, older than the other three and harder to dislodge, is the cultural framing of sleep as something the weak do. It is in the speech of fathers to sons, in the tone of senior colleagues mentoring juniors, and in the hierarchy of who answers a one a.m. email first. It responds, eventually, to the visible deterioration of the people who modelled it.
A third case, briefly — the inverse
A fifty-six-year-old hospital administrator in Wuse came in for an annual physical eighteen months ago with stage-one hypertension that had been creeping upward for three years, an HbA1c of 5.9, a fasting insulin in the high-normal range, and a STOP-BANG that scored him as intermediate-risk for OSA. A home sleep study returned an apnea-hypopnea index of twenty-two events per hour — moderate OSA. He was started on CPAP and supported through the first six weeks, which is the stretch where most patients quietly stop using the machine. His daytime blood pressure fell by an average of nine systolic and six diastolic within five weeks. His HbA1c, on no medication change, fell from 5.9 to 5.6 at three months. His wife volunteered, at the three-month follow-up, that he was a different man in the mornings. The compliance was the hard part, and it was won by the follow-up, not the prescription.
What serious sleep medicine actually looks like
The version of sleep medicine the Nigerian executive patient deserves is not a meditation app and a melatonin gummy. It has levels, and the levels matter.
The basic workup is a careful sleep history — habitual bedtime and wake time, weekend versus weekday pattern, snoring, witnessed apnea, daytime sleepiness, morning headache, nocturia, partner-reported leg movement — plus a validated screening questionnaire to triage which patients need a sleep study. The STOP-BANG is faster than the Berlin and more widely used. It includes ambulatory blood-pressure measurement where the office reading is borderline, and a morning testosterone in men over forty with low energy, low libido, or unexplained metabolic drift.
The sleep study is overnight polysomnography in a sleep laboratory, or a validated home test where the suspicion is OSA without complicating factors. Both are available in Lagos and Abuja in 2026, and both are dramatically underused. The standing position of the practice is that any patient over forty with two or more cardiovascular risk factors and any sign of disordered sleep should be tested liberally — the cost of missing OSA in this demographic, measured in stroke risk, atrial fibrillation, and the failure of antihypertensive therapy to work, is high, and the cost of the test is low.
The behavioural intervention, for chronic insomnia without OSA, is not sleep hygiene as the consumer wellness industry has commodified it. It is cognitive behavioural therapy for insomnia — sleep restriction, stimulus control, structured wind-down — delivered by a clinician trained for it. CBT-I is first-line for chronic insomnia in every major guideline of the last fifteen years, including those of the American Academy of Sleep Medicine and the UK National Institute for Health and Care Excellence. It outperforms zolpidem at six months and melatonin at twelve. It is rarely prescribed in Nigeria because trained clinicians are scarce and patients who expect it are scarcer.
Pharmacological intervention has a narrower role than most patients in this demographic believe. Short courses of a hypnotic with a defined end date are reasonable where clinically appropriate. The habitual benzodiazepine and Z-drug use that has quietly become common in the Nigerian executive class — diazepam and zolpidem prescribed informally, refilled informally, taken nightly for years — is a separate problem worth its own piece.
CPAP for confirmed obstructive sleep apnea is, in many of these patients, the single most consequential intervention available. Compliance failure at six months in unsupported settings runs above fifty percent. In a concierge follow-up structure — mask fitted properly, pressure titrated carefully, early intolerance met with adjustment rather than abandonment, patient reviewed serially over six months — the compliance rate is materially higher. The difference between the compliant and the abandoned-mask patient, in long-term cardiovascular outcomes, is large.
What concierge medicine does about this
The annual physical for a member over forty includes a real sleep history — not a single question at the end of the visit, but a structured conversation that takes ten minutes and establishes, on paper, where the patient's sleep actually sits against the literature.
Where the history flags a problem, the sleep study is ordered, not deferred. CPAP, when indicated, is fitted and followed through. CBT-I, when indicated, is referred to a clinician we know and reviewed at three months. The patient who promised in March to change something about how he sleeps is held to that promise in June, not in the following March.
Closing
There is a version of executive medicine, common in Nigerian primary care, in which sleep is mentioned briefly and almost apologetically near the end of the consultation, and in which the patient's twenty-year habit of five hours a night is left untreated while the antihypertensive doses creep upward and the HbA1c drifts and the testosterone falls and the Saturday mornings get quieter. That is the version most Nigerian principals are currently receiving, and it is the version this piece is written against.
If you are reading this and recognising yourself — the one a.m. bedtime, the six a.m. alarm, the third coffee at three, the wife who has mentioned twice that something is different — the next step is not a sleep tracker or a bottle of melatonin. It is a conversation with a physician who will take the history properly, place the finding in your medical context, and act on what it tells him.
The first hour is private and costs nothing.